Xylem, Inc. Achieves Fair Valuation Amid Strong Financial Performance and Growth

Feb 03 2026 04:02 PM IST
share
Share Via
Xylem, Inc. has recently adjusted its valuation metrics, now reflecting a fair assessment. The company showcases strong financial performance, with a notable price-to-earnings ratio of 35 and consistent positive results over the last seven quarters, highlighting its solid market position and financial health.
Xylem, Inc. Achieves Fair Valuation Amid Strong Financial Performance and Growth
Xylem, Inc., a key player in the industrial manufacturing sector, has recently undergone an evaluation adjustment that reflects a shift in its valuation metrics. The company's valuation grade has transitioned to a fair assessment, indicating a more favorable position compared to previous evaluations.
Key financial metrics highlight Xylem's robust performance. The price-to-earnings (P/E) ratio stands at 35, while the price-to-book value is recorded at 3.03. Additionally, the enterprise value to EBITDA ratio is 20.21, and the enterprise value to sales ratio is 3.94. These figures suggest a competitive stance within the industry, particularly as the company maintains a low debt-to-equity ratio, averaging at 8.61%. Xylem has demonstrated consistent financial strength, with positive results reported for the last seven consecutive quarters. The operating cash flow reached its highest at USD 1,224 million, and the dividend per share has also seen an increase, now at USD 4.97. With a return of 13.52% over the past year and profits rising by 32.9%, Xylem's financial health appears solid, reinforcing its position in the market. Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Xylem, Inc. overvalued or undervalued?
Nov 05 2025 11:11 AM IST
share
Share Via
Is Xylem, Inc. overvalued or undervalued?
Nov 03 2025 11:17 AM IST
share
Share Via
Is Xylem, Inc. overvalued or undervalued?
Nov 02 2025 11:10 AM IST
share
Share Via
Is Xylem, Inc. overvalued or undervalued?
Oct 21 2025 12:10 PM IST
share
Share Via
Is Xylem, Inc. overvalued or undervalued?
Oct 20 2025 12:27 PM IST
share
Share Via